ABCL

Abcellera Biologics Inc (ABCL)

US
$ 2.421.26%

Price Chart

Key Statistics

Market Cap
$ 1.34B
P/E Ratio
0.00
Revenue (TTM)
$ 23.11M
Volume
2.97M
52W High
$ 4.70
52W Low
$ 1.89
Dividend Yield
0.00%
Beta
0.36

Technicals

50-Day MA
2.9612
200-Day MA
2.7965
52 Week High
4.7
52 Week Low
1.8906

About ABCL

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.

Employees
596
Headquarters
Vancouver, BC
CEO
Dr. Carl L.G. Hansen Ph.D.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
JELD
JELD-WEN Holding In...
$ 4.40
12.24
LVS
Las Vegas Sands Cor...
$ 47.36
8.87
CCS
Century Communities...
$ 61.22
8.70
KTB
Kontoor Brands Inc....
$ 71.65
8.61
BBWI
Bath & Body Works I...
$ 32.40
8.14

Top Losers

Symbol/Name
LTP
% Chg
ACHR
Archer Aviation Inc...
$ 9.97
-8.11
AMC
AMC Entertainment H...
$ 2.87
-7.42
OKLO
Oklo Inc.
$ 52.29
-6.58
QS
QuantumScape Corpor...
$ 6.29
-6.40
SE
Sea Limited America...
$ 150.49
-5.96